Literature DB >> 12825991

Medical importance of biofilms in Candida infections.

L Julia Douglas1.   

Abstract

Many Candida infections involve biofilm formation on implanted devices such as an indwelling catheter, a prosthetic heart valve or a denture. Candida biofilms can be formed in vitro using several model systems. In the simplest of these, organisms are grown on the surfaces of small discs of catheter material or denture acrylic. Biofilms of C. albicans prepared in this way consist of matrix-enclosed microcolonies containing yeasts, hyphae and pseudohyphae, arranged in a bilayer structure. Candida biofilms are resistant to a range of antifungal agents in current clinical use, including amphotericin B and fluconazole. Current research suggests that multiple mechanisms are involved in biofilm drug resistance.

Entities:  

Year:  2002        PMID: 12825991

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  56 in total

Review 1.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

2.  Secreted aspartate proteinases, a virulence factor of Candida spp.: occurrence among clinical isolates.

Authors:  P Hamal; J Dostál; V Raclavský; M Krylová; I Pichová; O Hrusková-Heidlngsfeldová
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

Review 3.  Candida biofilms: an update.

Authors:  Gordon Ramage; Stephen P Saville; Derek P Thomas; José L López-Ribot
Journal:  Eukaryot Cell       Date:  2005-04

4.  Antibody-mediated immobilization of Cryptococcus neoformans promotes biofilm formation.

Authors:  Emma J Robertson; Arturo Casadevall
Journal:  Appl Environ Microbiol       Date:  2009-02-27       Impact factor: 4.792

5.  Anaerobic growth of Candida albicans does not support biofilm formation under similar conditions used for aerobic biofilm.

Authors:  Swarajit K Biswas; W LaJean Chaffin
Journal:  Curr Microbiol       Date:  2005-06-27       Impact factor: 2.188

6.  A 5' UTR-mediated translational efficiency mechanism inhibits the Candida albicans morphological transition.

Authors:  Delma S Childers; Vasanthakrishna Mundodi; Mohua Banerjee; David Kadosh
Journal:  Mol Microbiol       Date:  2014-03-28       Impact factor: 3.501

7.  Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs.

Authors:  Jeniel E Nett; David R Andes
Journal:  Microbiol Spectr       Date:  2015-06

8.  Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1- and Sun41-dependent mechanisms.

Authors:  Mohua Banerjee; Priya Uppuluri; Xiang R Zhao; Patricia L Carlisle; Geethanjali Vipulanandan; Cristina C Villar; José L López-Ribot; David Kadosh
Journal:  Eukaryot Cell       Date:  2012-12-07

9.  Photodynamic inactivation of Candida albicans mediated by a low density of light energy.

Authors:  Gabriel Salles Barbério; Soraia Veloso da Costa; Mariana dos Santos Silva; Thaís Marchini de Oliveira; Thiago Cruvinel Silva; Maria Aparecida de Andrade Moreira Machado
Journal:  Lasers Med Sci       Date:  2013-03-14       Impact factor: 3.161

Review 10.  Fungal biofilms and drug resistance.

Authors:  Mary Ann Jabra-Rizk; William A Falkler; Timothy F Meiller
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.